CORBUS PHARMACEUTICALS HLDGS's ticker is CRBP and the CUSIP is 21833P103. A total of 113 filers reported holding CORBUS PHARMACEUTICALS HLDGS in Q4 2020. The put-call ratio across all filers is 0.88 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2020 | $103,000 | -78.5% | 57,213 | 0.0% | 0.02% | -79.3% |
Q2 2020 | $480,000 | +60.0% | 57,213 | 0.0% | 0.08% | +34.4% |
Q1 2020 | $300,000 | -3.8% | 57,213 | 0.0% | 0.06% | +19.6% |
Q4 2019 | $312,000 | +11.8% | 57,213 | 0.0% | 0.05% | +4.1% |
Q3 2019 | $279,000 | -29.5% | 57,213 | 0.0% | 0.05% | -29.0% |
Q2 2019 | $396,000 | -0.5% | 57,213 | 0.0% | 0.07% | -2.8% |
Q1 2019 | $398,000 | -27.0% | 57,213 | -38.7% | 0.07% | -34.9% |
Q4 2018 | $545,000 | -22.6% | 93,264 | 0.0% | 0.11% | -8.4% |
Q3 2018 | $704,000 | +93.4% | 93,264 | +29.5% | 0.12% | +77.6% |
Q2 2018 | $364,000 | -17.1% | 72,001 | 0.0% | 0.07% | -19.3% |
Q1 2018 | $439,000 | -14.1% | 72,001 | 0.0% | 0.08% | -11.7% |
Q4 2017 | $511,000 | -0.8% | 72,001 | 0.0% | 0.09% | -4.1% |
Q3 2017 | $515,000 | +47.1% | 72,001 | +29.8% | 0.10% | +42.0% |
Q2 2017 | $350,000 | -23.6% | 55,489 | 0.0% | 0.07% | -25.0% |
Q1 2017 | $458,000 | -2.3% | 55,489 | 0.0% | 0.09% | -3.2% |
Q4 2016 | $469,000 | +73.1% | 55,489 | +39.0% | 0.10% | +72.7% |
Q3 2016 | $271,000 | – | 39,931 | – | 0.06% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Knoll Capital Management, LLC | 5,045,870 | $6,307,000 | 4.30% |
ETF MANAGERS GROUP, LLC | 8,103,641 | $10,130,000 | 0.22% |
AdvisorShares Investments LLC | 271,873 | $340,000 | 0.08% |
Platform Technology Partners | 60,000 | $75,000 | 0.04% |
PINNACLE ASSOCIATES LTD | 942,079 | $1,178,000 | 0.02% |
HRT FINANCIAL LP | 883,510 | $1,104,000 | 0.02% |
Virtu Financial LLC | 153,908 | $192,000 | 0.02% |
Tekla Capital Management LLC | 413,481 | $517,000 | 0.02% |
Aries Wealth Management | 23,400 | $33,000 | 0.02% |
IQ EQ FUND MANAGEMENT (IRELAND) Ltd | 56,932 | $71,000 | 0.02% |